LaPlume Joseph W's Form 4 filing
Charles River Laboratories International, Inc. (CRL) · filed Aug 10, 2021
- Accession no.
- 0001127602-21-023433
- Filed
- Aug 10, 2021
- Trade date
- Aug 6, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $1.49M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| LaPlume Joseph WCIK 0001767215 | Officer (EVP, Corp Strategy & Develop) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2021 | Common Stock | SSaleDisposed | −1,458 | $400.91F1 | −$584,526.78 | 10,704 | Direct | |
| Aug 6, 2021 | Common Stock | SSaleDisposed | −900 | $401.66F2 | −$361,494 | 9,804 | Direct | |
| Aug 6, 2021 | Common Stock | SSaleDisposed | −1,042 | $402.43F3 | −$419,332.06 | 8,762 | Direct | |
| Aug 6, 2021 | Common Stock | SSaleDisposed | −300 | $409.40F4 | −$122,820 | 8,462 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $400.22 to $401.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F2
This transaction was executed in multiple trades at prices ranging from $401.48 to $401.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $402.25 to $402.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $409.10 to $409.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.